Rubomycin-induced cardiomyopathy in rats and the potential for therapy with a peptide preparation from the heart
Andreeva, L.I.; Khavinson, V.K.
Biulleten' Eksperimental'noi Biologii i Meditsiny 116(9): 233-235
1993
ISSN/ISBN: 0365-9615 PMID: 8117986 Document Number: 417394
The study has shown the efficiency of heart peptide preparation (HP) in the management of rubomycin cardiomyopathy. HP does not prevent rat mortality if rubomycin doses are very large, but it can improve a state of survived animals. HP affects restoration processes in myocardium improving the myocardial contractibility.
Document emailed within 1 workday
Related Documents
Mettler, F.P.; Young, D.M.; Ward, J.M. 1977: Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats Cancer Research 37(8 Part 1): 2705-2713Kim, V.K.; Smoryzanova, O.A.; Riabchenko, N.I.; Dedenkov, A.N. 1981: Comparative study of the toxicity and antitumor activity of a DNA-rubomycin complex and free rubomycin Antibiotiki 26(5): 361-365
Zhu, X.X.; Zhou, X.P.; Zhong, X.L.; Zhong, C.S.; Yu, Y.F. 1993: Streptozotocin induced cardiomyopathy in diabetic rats Chinese Medical Journal 106(6): 463-466
Klebanov, G.I.; Naumov, O.G.; Vladimirov, I.A.; Ribarov, S.R.; Peneva, V. 1990: Functional activity of polymorphonuclear leukocytes in isoprenaline-induced cardiomyopathy in rats Biulleten' Eksperimental'noi Biologii i Meditsiny 110(12): 592-594
Pelosi, G.; Volante, M.; Papotti, M.; Sonzogni, A.; Masullo, M.; Viale, G. 2006: Peptide receptors in neuroendocrine tumors of the lung as potential tools for radionuclide diagnosis and therapy Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 50(4): 272-287
Li, H-Li.; Liu, B.; Zhou, L-wang.; Yu, W-han. 2005: Change and significance of nuclear factor-kappaB in adriamycin induced cardiomyopathy in rats Chinese Medical Journal 118(2): 111-115
Sheppard, R.J.; Racine, N.; Roof, A.; Ducharme, A.; Blanchet, M.; White, M. 2007: Heart rate recovery--a potential marker of clinical outcomes in heart failure patients receiving beta-blocker therapy Canadian Journal of Cardiology 23(14): 1135-1138
Adams, S.; Albericio, F.; Alsina, J.; Smith, E.R.; Humphreys, R.E. 1997: Biological activity and therapeutic potential of homologs of an Ii peptide which regulates antigenic peptide binding to cell surface MHC class II molecules Arzneimittel-Forschung 47(9): 1069-1077
Wang, G.-y.; Wang, Y.-m.; Zhang, L.-n.; Li, Q.; Yue, H.; Song, C.-m.; Feng, J.-k.; Wang, N. 2007: Effect of resveratrol on heart function of rats with adriamycin-induced heart failure Zhongguo Zhong Yao Za Zhi 32(15): 1563-1565
Kambayashi, M.; Kumada, T. 1993: Pathophysiology and current therapy of congestive heart failure due to idiopathic cardiomyopathy Nihon Rinsho. Japanese Journal of Clinical Medicine 51(5): 1328-1332
Meerson, F.Z.; Nurmukhambetov, A.N.; Dzhanbaeva, G.E.; Gutkin, D.V. 1987: Free-radical lipid oxidation and DNA synthesis in the heart in adriablastin-induced cardiomyopathy and the action of the antioxidant ionol Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 4: 66-68
Martins, E.; Cardoso, J.é S.; Campelo, M.; Amorim, S.; Moura, B.; Maciel, M.J.úl.; Gonçalves, F.R. 2009: Survival of patients with familial dilated cardiomyopathy on optimal heart failure therapy Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 28(3): 263-268
Zhao, M.; Zhang, Z.; Liang, J.; Li, Y. 2010: Protective effect of marine collagen peptide on liver and renal injuries in diabetic rats induced by alloxan Wei Sheng Yan Jiu 39(2): 147-149
Katano, Y.; Nakagawa, Y.; Shimamoto, N.; Sakai, K.; Otorii, T.; Imai, S. 1980: Using the isolated atrial preparation of the guinea-pig and the canine heart lung preparation (HLP) supported by a donor, the effects of guanfacine on the heart, coronary circulation and myocardial energy metabolism were studied and compared with those of clonidine Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(5): 281-292
Vasilets, L.A.; Guseva, T.I.; Mokh, V.P. 1985: Comparative analysis of the changes in myocardial electrical and contractile activity in rats exposed to rubomycin and its nitroxyl derivative Farmakologiia i Toksikologiia 48(6): 33-37
Masuda, Y. 2000: Differential diagnosis of idiopathic cardiomyopathy from ischemic cardiomyopathy and hypertensive heart disease using non-invasive methods Nihon Rinsho. Japanese Journal of Clinical Medicine 58(1): 218-222
Hirano, T. 1997: Peptide leukotriene receptor antagonist diminishes pancreatic edema formation in rats with cerulein-induced acute pancreatitis Scandinavian Journal of Gastroenterology 32(1): 84-88
Schüpbach, R.; Schneider, J. 1988: Incidence of double-nucleated heart muscle fibers in hearts with dilated cardiomyopathy and secondary pressure or volume-induced hypertrophy Zeitschrift für Kardiologie 77(12): 780-783
Vaĭkhanskaia, T.G.; Kurushko, T.V.; Sidorenko, I.V.; Koptiukh, T.M.; Gul', L.M.; Mel'nikova, O.P.; Golenishcha, V.F.; Kovalenko, O.N. 2013: Electrocardiographic predictors of response to cardiac resynchronization therapy of heart failure in patients with dilated cardiomyopathy Kardiologiia 53(3): 48-54
Xu, Z.; Wu, W.; Lan, T.; Zhang, X. 2009: Protective effects of extract of Ginkgo biloba on adriamycin-induced heart failure and its mechanism: role of ghrelin peptide Zhongguo Zhong Yao Za Zhi 34(21): 2786-2789